Cargando…

Association of Infliximab and Vedolizumab Trough Levels with Reported Rates of Adverse Events: A Cross-Sectional Study

Infliximab and vedolizumab are effective treatments for inflammatory bowel disease (IBD), although associated with adverse events (AE). While low or non-existent drug levels and positive antidrug antibodies have been associated with therapeutic failure, there is no clear association between higher d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veisman, Ido, Barzilay, Oranit, Bruckmayer, Liora, Haj-Natour, Ola, Kopylov, Uri, Eliakim, Rami, Ben-Horin, Shomron, Ungar, Bella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8471987/ https://www.ncbi.nlm.nih.gov/pubmed/34575376 http://dx.doi.org/10.3390/jcm10184265

Ejemplares similares

Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
por: Levartovsky, Asaf, et al.
Publicado: (2023)

Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure
por: Ungar, Bella, et al.
Publicado: (2015)

Acute Chest Pain as an Infusion Reaction to Vedolizumab
por: Levartovsky, Asaf, et al.
Publicado: (2022)

Adverse Clinical Outcomes among Inflammatory Bowel Disease Patients Treated for Urinary Tract Infection
por: Ukashi, Offir, et al.
Publicado: (2022)

Incidentally Diagnosed Asymptomatic Crohn’s Disease: A Retrospective Cohort Study of Long-Term Clinical Outcomes
por: Grinman, Ana, et al.
Publicado: (2022)

Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening
por: Ben-Shatach, Zohar, et al.
Publicado: (2022)

Spatiotemporal analysis of small bowel capsule endoscopy videos for outcomes prediction in Crohn’s disease
por: Kellerman, Raizy, et al.
Publicado: (2023)

Capsule Endoscopy in Inflammatory Bowel Disease: Panenteric Capsule Endoscopy and Application of Artificial Intelligence
por: Ukashi, Offir, et al.
Publicado: (2023)

Ustekinumab in ulcerative colitis‐ insights from the real‐world data
por: Veisman, Ido, et al.
Publicado: (2022)

Outcome of inflammatory bowel disease patients with prior malignancy
por: Shani, Uria, et al.
Publicado: (2023)

Diagnostic significance of mesenteric lymph node involvement in proximal small bowel Crohn’s disease
por: Maconi, Giovanni, et al.
Publicado: (2022)

Thromboprophylaxis for Hospitalized Patients with Inflammatory Bowel Disease—Are We There Yet?
por: Levartovsky, Asaf, et al.
Publicado: (2020)

The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?
por: Yablecovitch, Doron, et al.
Publicado: (2018)

Middle small-bowel segment Lewis score may predict long-term outcomes among patients with quiescent Crohn’s disease
por: Ukashi, Offir, et al.
Publicado: (2023)

Impact of Vedolizumab on Extraintestinal Manifestations in Inflammatory Bowel Disease: Results From a Descriptive, Retrospective, Real-world Study
por: Kopylov, Uri, et al.
Publicado: (2023)

Disproportionately Low Albumin and High Neutrophil-to-Lymphocyte Ratio in Small Bowel Adenocarcinoma Patients With Long-Duration Crohn's Disease
por: Veisman, Ido, et al.
Publicado: (2022)

The accuracy of intestinal ultrasound compared with small bowel capsule endoscopy in assessment of suspected Crohn’s disease in patients with negative ileocolonoscopy
por: Carter, Dan, et al.
Publicado: (2018)

Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis
por: Tham, Yuen Sau, et al.
Publicado: (2018)

Helicobacter pylori prevalence and clinical significance in patients with quiescent Crohn’s disease
por: Lahat, Adi, et al.
Publicado: (2017)

Predictors of mortality in inflammatory bowel disease patients treated for pneumonia
por: Ukashi, Offir, et al.
Publicado: (2020)

Machine learning for prediction of intra-abdominal abscesses in patients with Crohn’s disease visiting the emergency department
por: Levartovsky, Asaf, et al.
Publicado: (2021)

Prediction of Recurrent Emergency Department Visits among Patients with Crohn’s Disease: A Retrospective Study
por: Mahajna, Hussein, et al.
Publicado: (2020)

Therapeutic drug monitoring in inflammatory bowel disease
por: Kopylov, Uri, et al.
Publicado: (2014)

Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis
por: Ben-Horin, Shomron, et al.
Publicado: (2022)

Keeping it simple: mental health assessment in the Gastroenterology Department – using the Hospital Anxiety and Depression Scale (HADS) for IBD patients in Israel
por: Avinir, Asia, et al.
Publicado: (2022)

Deep Learning Multi-Domain Model Provides Accurate Detection and Grading of Mucosal Ulcers in Different Capsule Endoscopy Types
por: Kratter, Tom, et al.
Publicado: (2022)

Top 25 cited articles on Covid-19 and IBD: A bibliometric analysis
por: Veisman, Ido, et al.
Publicado: (2022)

Partners of patients with inflammatory bowel disease: how important is their support?
por: Lahat, Adi, et al.
Publicado: (2014)

Signs and Symptoms of Acute Bowel Inflammation and the Risk of Progression to Inflammatory Bowel Disease: A Retrospective Analysis
por: Levartovsky, Asaf, et al.
Publicado: (2022)

Advances in the development of new biologics in inflammatory bowel disease
por: Ungar, Bella, et al.
Publicado: (2016)

Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease
por: Vaughn, Byron P., et al.
Publicado: (2020)

Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease
por: Grišić, Ana‐Marija, et al.
Publicado: (2021)

Vedolizumab is superior to infliximab in biologic naïve patients with ulcerative colitis
por: Sablich, Renato, et al.
Publicado: (2023)

Magnetic resonance enterography or video capsule endoscopy – what do Crohn’s disease patients prefer?
por: Lahat, Adi, et al.
Publicado: (2016)

A Convolutional Neural Network Deep Learning Model Trained on CD Ulcers Images Accurately Identifies NSAID Ulcers
por: Klang, Eyal, et al.
Publicado: (2021)

Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists
por: Vaisman-Mentesh, Anna, et al.
Publicado: (2019)

Vedolizumab trough level monitoring in inflammatory bowel disease: a state-of-the-art overview
por: Pouillon, Lieven, et al.
Publicado: (2019)

Is there a correlation between infliximab trough levels and the development of adverse events in patients with inflammatory bowel disease?
por: Theodoraki, Eirini, et al.
Publicado: (2021)

Risk factors and prediction algorithm for advanced neoplasia on screening colonoscopy for average-risk individuals
por: Ukashi, Offir, et al.
Publicado: (2022)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_76k5uk8iscom29aqmqbbavj5if